VABILO NA PREDAVANJE SERENE ZACCHIGNA
Interreg V-A Italija-Slovenija 2014-2020 - TRAIN - Big Data in Modeli Bolezni: Čezmejna Platforma validiranih kompletov za Biotehnološko Industrijo
Interreg V-A Italija-Slovenija 2014-2020 - TRAIN - Big Data in Modeli Bolezni: Čezmejna Platforma validiranih kompletov za Biotehnološko Industrijo
Vljudno vas vabimo na predavanje Serene Zacchigna (International Centre for Genetic Engineering and Biotechnology - ICGEB) z naslovom "Novel genes for old hearts" v petek, 25. maja 2018, ob 10:45 uri v predavalnici MPŠ, Jamova 39, Ljubljana, soba N205 (2. nadstropje).
Predavanje bo v angleščini.
Novel genes for old hearts
Serena Zacchigna, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy
The burden of cardiovascular disease is enormous, largely as a consequence of the aging of the population, the incapacity of the heart to regenerate once damaged and the lack of novel drugs over the last 20 years. Thus, there is an impelling need to develop novel therapeutic strategies aimed at inducing cardiac repair and regeneration. In contrast to other species that regenerate the heart during the adult life, in mammals, damage to the myocardium is mended by a scarring mechanism. However, multiple evidence now indicates that a limited capacity of myocardial renewal also exists in adult individuals, and we are therefore actively searching for factors able to foster this regenerative capacity. Using viral vectors based on the Adeno-Associated Virus (AAV), which transduce the heart at very high efficiency, we are undertaking an exhaustive approach to identify extracellular proteins promoting cardiac repair, selected from an AAV library corresponding to the mouse secretome (1200+ secreted proteins). A second approach entails high throughput screening of microRNAs promoting cardiomyocyte proliferation. Starting from a whole genome human microRNA library, we have identified a few microRNAs endowed with the capacity of promoting expansion of cardiomyocytes in cell culture, inducing massive cardiac hyperplasty in the neonatal heart and improving cardiac function after myocardial infarction. These microRNA function by directly activating the proliferative potential of differentiated cardiomyocytes, thus bypassing the requirement of stem cell expansion and differentiation.